What Karyopharm Therapeutics Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 4 | 21 |
| Total trades | 4 | 40 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 182,813 |
| Disposed | 5,374 | 41,077 |
| Net activity | −5,374 | +141,736 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Abate Kristin | Chief Accounting Officer | Oct 16 | Open-market sale · S | −4,788 | $0.34 | −$1.65K | 18,616 |
| Abate Kristin | Chief Accounting Officer | Oct 01 | Open-market sale · S | −378 | $1.19 | −$450 | 23,404 |
| Abate Kristin | Chief Accounting Officer | Sep 01 | Open-market sale · S | −19 | $2.02 | −$38.4 | 23,782 |
| Poulton Stuart | EVP, Chief Development Officer | Jul 28 | Open-market sale · S | −189 | $7.10 | −$1.34K | 94,632 |
| Su Zhen | Director | May 21 | Grant / award · A | +15,508 | — | — | 15,508 |
| Greene Barry E | Director | May 21 | Grant / award · A | +15,508 | — | — | 16,415 |
| Bohlin Garen G | Director | May 21 | Grant / award · A | +15,508 | — | — | 18,517 |
| Schor Chen | Director | May 21 | Grant / award · A | +15,508 | — | — | 15,508 |
| Pakianathan Deepika | Director | May 21 | Grant / award · A | +15,508 | — | — | 15,508 |
| Oliger Christy J. | Director | May 21 | Grant / award · A | +15,508 | — | — | 15,508 |
| Mano Michael | EVP, CLO&Secretary | May 14 | Open-market sale · S | −266 | $9.50 | −$2.53K | 94,398 |
| Paulson Richard A. | President and CEO | May 14 | Open-market sale · S | −2,203 | $9.50 | −$20.9K | 269,747 |
| Rangwala Reshma | EVP & Chief Medical Officer | May 14 | Open-market sale · S | −408 | $9.50 | −$3.88K | 56,829 |
| Cheng Sohanya Roshan | EVP & Chief Commercial Officer | May 14 | Open-market sale · S | −324 | $9.50 | −$3.08K | 107,940 |
| Poulton Stuart | EVP, Chief Development Officer | May 14 | Open-market sale · S | −403 | $9.50 | −$3.83K | 94,821 |
| Abate Kristin | Chief Accounting Officer | May 14 | Open-market sale · S | −53 | $9.50 | −$504 | 23,801 |
| Mano Michael | EVP, CLO&Secretary | May 13 | Grant / award · A | +700 | — | — | 94,664 |
| Paulson Richard A. | President and CEO | May 13 | Grant / award · A | +4,920 | — | — | 271,950 |
| Rangwala Reshma | EVP & Chief Medical Officer | May 13 | Grant / award · A | +947 | — | — | 57,237 |
| Cheng Sohanya Roshan | EVP & Chief Commercial Officer | May 13 | Grant / award · A | +947 | — | — | 108,264 |
Loading...
